BCM
CMD

Bayesian Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Bayesian Capital Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,381
Closed -$403K – 855
2018
Q3 		$403K Buy
+4,381
New +$417K 0.07% 379
2017
Q4 		– Sell
-5,040
Closed -$475K – 781
2017
Q3 		$475K Buy
+5,040
New +$398K 0.11% 278

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Bayesian Capital Management's CMD Position: Q4 2018 in Review

Bayesian Capital Management sold out of Cantel Medical Corporation (CMD) in Q4 2018, closing a stake of 4,381 shares — an estimated $403K sold.

Bayesian Capital Management first reported a position in CMD in Q3 2017 and held it in 2 quarters. The position peaked at $475K in Q3 2017. 253 funds tracked by Wall St. Rank hold CMD as of Q4 2018.

  • Bayesian Capital Management reported no remaining Cantel Medical Corporation position as of Q4 2018 after selling out during the quarter.
  • Bayesian Capital Management sold 4,381 Cantel Medical Corporation shares in Q4 2018, an estimated $403K.
  • Bayesian Capital Management first reported a position in Cantel Medical Corporation in Q3 2017 and held it in 2 quarters.
  • Bayesian Capital Management's Cantel Medical Corporation position peaked at $475K in Q3 2017.
  • 253 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2018.

Based on Bayesian Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.